|
|
645 Madison Avenue; Suite 502
New York, NY 10022 USA
phone:212.659.0703
fax:
|
|
| Symbol |
private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.ausambiotech.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| AusAm is developing new methods to identify and treat major diseases. |
|
| Management |
| WAYNE COMPER, CHIEF SCIENCE OFFICER
SARA BARRINGTON, CHIEF FINANCIAL OFFICER
SAM HOPKINS, DIRECTOR, CLINICAL TRIALS
TANYA OSICKA, SENIOR RESEARCH COORDINATOR
JAMES R. MCCULLOUGH, STRATEGY CONSULTANT |
| |
|
|
| |
|
| Keywords |
| attachment inhibitors, HIV, polysaccharide-based compounds, HIVAIDS |
|
|
|
| Description |
|
AusAm - Through our innovative research, we are developing advanced urinary diagnostics for use with patients at risk for kidney diseases and cardiovascular diseases. |
|
| Products / Services |
DES6' Viral Attachment Inhibitor
Accumin'
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members